| Aug 27 |
Aadi Bioscience downgraded to Neutral, shares fall
|
| Aug 22 |
Aadi Bioscience cut to hold at Jefferies following Fyarro failure in solid tumors
|
| Aug 21 |
Why Keysight Technologies Shares Are Trading Higher By Around 11%; Here Are 20 Stocks Moving Premarket
|
| Aug 20 |
Aadi plunges 36% as phase 2 trial for solid tumors asset unlikely to meet goal
|
| Aug 20 |
Aadi Bioscience Provides PRECISION1 Trial and Corporate Updates
|
| Aug 10 |
Aadi Bioscience, Inc. (AADI) Q2 2024 Earnings Call Transcript
|
| Aug 10 |
Aadi Bioscience, Inc. 2024 Q2 - Results - Earnings Call Presentation
|
| Aug 7 |
Aadi Bioscience GAAP EPS of -$0.54 beats by $0.12, revenue of $6.18M beats by $0.08M
|
| Aug 7 |
Aadi Bioscience Announces Financial Results for the Second Quarter 2024 and Provides Corporate Update
|
| Jul 31 |
Aadi Bioscience to Report Second Quarter 2024 Results and Corporate Update
|
